WEBSITE BSE:506640 NSE: ZR2 Inc. Year: 1939 Industry: Chemicals My Bucket: Add Stock
Last updated: 10:30
Gujchem Distillers India Limited (GDIL) has a rich history dating back to 1911. Initially set up as a proprietary concern, it later became Sardesai Brothers Private Limited in 1939. In 1961, it transformed into a public limited company known as Sardesai Brothers Limited. The company’s name changed to the present name, ‘Gujchem Distillers India Limited,’ in 1974. It was later converted into a private limited Company as Sardesai Brothers Private Limited in 1939. In the year 1961, it was converted into a public limited Company ...Read More
Gujchem Distillers India Limited (GDIL) has a rich history dating back to 1911. Initially set up as a proprietary concern, it later became Sardesai Brothers Private Limited in 1939. In 1961, it transformed into a public limited company known as Sardesai Brothers Limited. The company’s name changed to the present name, ‘Gujchem Distillers India Limited,’ in 1974. It was later converted into a private limited Company as Sardesai Brothers Private Limited in 1939. In the year 1961, it was converted into a public limited Company under the name and style as Sardesai Brothers Limited. The name of the Company was changed to the present name ‘Gujchem Distillers India Limited’ in the year 1974. GDIL is engaged in the manufacture and sale of industrial alcohol, acetaldehyde, acetic acid, and other auxiliaries and chemicals. Monochloro acetic acid and carboxy methyl cellulose is offered too. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹278 Cr.
Stock P/E 3083.2
P/B 2
Current Price ₹174.7
Book Value ₹ 88.8
Face Value 1
52W High ₹437
Dividend Yield 0.06%
52W Low ₹ 90
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Sep 2022 | Dec 2022 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 |
| Profit After Tax | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | 0 | -0.2 | -0 | -0.2 | -0.7 | 0.3 | 0.9 | 0.8 | 0.6 |
| #(Fig in Cr.) | Mar 2025 | TTM |
|---|---|---|
| Net Sales | 1 | 0 |
| Other Income | 1 | 1 |
| Total Income | 2 | 1 |
| Total Expenditure | 2 | 0 |
| Operating Profit | 0 | 0 |
| Interest | 0 | 0 |
| Depreciation | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 |
| Profit Before Tax | 0 | 0 |
| Provision for Tax | 0 | 0 |
| Profit After Tax | 0 | 0 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 0 | 0 |
| Adjusted Earnings Per Share | 0.3 | 2.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -38% | 42% | 78% | 32% |
| ROE Average | 1% | 1% | 1% | 1% |
| ROCE Average | 0% | 0% | 0% | 0% |
| #(Fig in Cr.) | Mar 2025 |
|---|---|
| Shareholder's Funds | 59 |
| Minority's Interest | 0 |
| Borrowings | 80 |
| Other Non-Current Liabilities | 0 |
| Total Current Liabilities | 0 |
| Total Liabilities | 140 |
| Fixed Assets | 0 |
| Other Non-Current Assets | 119 |
| Total Current Assets | 20 |
| Total Assets | 140 |
| #(Fig in Cr.) | Mar 2025 |
|---|---|
| Opening Cash & Cash Equivalents | 4 |
| Cash Flow from Operating Activities | 31 |
| Cash Flow from Investing Activities | -117 |
| Cash Flow from Financing Activities | 100 |
| Net Cash Inflow / Outflow | 15 |
| Closing Cash & Cash Equivalent | 19 |
| # | Mar 2025 |
|---|---|
| Earnings Per Share (Rs) | 0.25 |
| CEPS(Rs) | 0.37 |
| DPS(Rs) | 0.1 |
| Book NAV/Share(Rs) | 47.48 |
| Core EBITDA Margin(%) | -26.15 |
| EBIT Margin(%) | 13.94 |
| Pre Tax Margin(%) | 13.51 |
| PAT Margin (%) | 6.04 |
| Cash Profit Margin (%) | 8.95 |
| ROA(%) | 0.06 |
| ROE(%) | 0.53 |
| ROCE(%) | 0.15 |
| Receivable days | 5.76 |
| Inventory Days | 0 |
| Payable days | 24.99 |
| PER(x) | 1108.03 |
| Price/Book(x) | 5.9 |
| Dividend Yield(%) | 0.04 |
| EV/Net Sales(x) | 107.8 |
| EV/Core EBITDA(x) | 639.59 |
| Net Sales Growth(%) | 0 |
| EBIT Growth(%) | 0 |
| PAT Growth(%) | 0 |
| EPS Growth(%) | 0 |
| Debt/Equity(x) | 4.74 |
| Current Ratio(x) | 126.73 |
| Quick Ratio(x) | 126.73 |
| Interest Cover(x) | 32.06 |
| Total Debt/Mcap(x) | 0.8 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.96 | 60.96 | 60.96 | 60.96 | 60.96 | 60.96 | 60.96 | 61 | 61 | 61 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Public | 38.98 | 38.98 | 38.98 | 38.98 | 38.98 | 38.98 | 38.98 | 38.94 | 38.94 | 38.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
